All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • GM103Phase 21 trial

    GeneMedicine Co., Ltd. · Head and Neck Cancer, Malignant Melanoma, Colorectal Cancer

  • GNS561Phase 21 trial

    Genfit · Cholangiocarcinoma

  • GSK4418959Phase 21 trial

    GSK · Neoplasms, Colorectal, Solid Tumor, Colon Cancer

  • GSK4524101Phase 21 trial

    GSK · Neoplasms

  • GSK5458514Phase 21 trial

    GSK · Neoplasms, Prostate

  • GSK5460025Phase 21 trial

    GSK · Neoplasms, Colorectal, Neoplasms

  • GSK5471713Phase 21 trial

    GSK · Neoplasms, Prostate

  • GSK5864399Phase 21 trial

    GSK · Solid Tumours

  • GST101Phase 21 trial

    Genuine Seed Therapeutics (Zhuhai) Co., Ltd. · RAS-mutant Advanced Solid Tumors

  • GT101Phase 21 trial

    Grit Biotechnology · Recurrent or Metastatic Cervical Cancer

  • GTAEXS617REC-617Phase 21 trial

    Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)

  • GVV858Phase 21 trial

    Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer

  • HA131Phase 21 trial

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC)

  • HB-201HB-202 alternating using CD8 PET Tracer, Zr-Df-IAB22M2CPhase 21 trial

    Hookipa Biotech GmbH · HPV-Related Squamous Cell Carcinoma

  • HB-202Phase 21 trial

    Hookipa Biotech GmbH · HPV-Related Squamous Cell Carcinoma

  • HB0036Phase 21 trial

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Advanced Solid Tumor, NSCLC

  • HB0052Phase 21 trial

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Solid Tumors

  • HCB101Phase 21 trial

    FBD Biologics Limited · Solid Cancer

  • HCW9218Phase 21 trial

    ImmunityBio, Inc. · Advanced Pancreatic Carcinoma

  • HG146Phase 21 trial

    HitGen Inc. · Adenoid Cystic Carcinoma, Head and Neck Cancer

  • HLX53Phase 21 trial

    Shanghai Henlius Biotech · Carcinoma, Hepatocellular

  • HMBD-001Phase 21 trial

    Hummingbird Bioscience · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma

  • HP518Phase 21 trial

    Hinova Pharmaceuticals Inc. · Metastatic Castration-resistant Prostate Cancer

  • HP568Phase 21 trial

    Hinova Pharmaceuticals Inc. · Breast Cancer

  • HRS-1738Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · PET Imaging in Patients With Prostate Cancer

  • HRS-6213Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Patients With Solid Tumors

  • HRS-6719Phase 21 trial

    Shandong Suncadia Medicine Co., Ltd. · Advanced/Metastatic Solid Tumors

  • HRS-6768Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Advanced Solid Tumors

  • HRS-717Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer

  • HRS-7172Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer

  • HRS-8364Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Solid Tumor

  • HRS-9308Phase 21 trial

    Chengdu Suncadia Medicine Co., Ltd. · Solid Tumor

  • HRX215Phase 21 trial

    HepaRegeniX GmbH · Liver Resection, Colorectal Carcinoma Liver Metastases

  • HS-10365Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Nonsmall Cell Lung Cancer

  • HS-10516Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Advanced Clear Cell Renal Cell Carcinoma

  • HS-10566Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · High-risk Non-muscle-invasive Bladder Cancer

  • HS-20105Phase 21 trial

    Hansoh BioMedical R&D Company · Advanced Solid Tumor

  • HSK39775Phase 21 trial

    Xizang Haisco Pharmaceutical Co., Ltd · Advanced Solid Tumors

  • HSK42360-NaPhase 21 trial

    Haisco Pharmaceutical Group Co., Ltd. · Metastatic Colorectal Cancer (CRC)

  • HST-1011Phase 21 trial

    HotSpot Therapeutics, Inc · Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer

  • HX009Phase 21 trial

    Hangzhou Hanx Biopharmaceuticals, Ltd. · Biliary Tract Cancer, Melanoma

  • HX044Phase 21 trial

    Hanx Biopharmaceuticals (Wuhan) Co., Ltd. · Advanced Solid Tumor Malignancies

  • HX111Phase 21 trial

    Hanx Biopharmaceuticals (Wuhan) Co., Ltd. · Solid Tumor and Lymphoma

  • HX301Phase 21 trial

    Hangzhou Hanx Biopharmaceuticals, Ltd. · Glioma

  • HY-0102Phase 21 trial

    Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer

  • HY05350Phase 21 trial

    Sichuan Huiyu Pharmaceutical Co., Ltd · Advanced Solid Tumor

  • IAM1363Phase 21 trial

    Iambic Therapeutics, Inc · HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer

  • IBI129Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Solid Tumor

  • IBI133Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Locally Advanced Unresectable or Metastatic Solid Tumors

  • IBI3005Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Solid Tumor

NewerPage 19 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.